Back to All Events

Peripheral and Central Nervous System Drugs Advisory Committee

  • IQVIA Solutions Denmark A/S Denmark (map)

On Wednesday 30 March 2022, the Peripheral and Central Nervous System Drugs Advisory Committee ([PCNS]) has scheduled a meeting to discuss a new drug application (NDA) 216660, for oral formulation (suspension powder) of sodium phenylbutyrate/taurursodiol (AMX0035) for the treatment of Amyotrophic lateral sclerosis (ALS)

Source:: https://www.fda.gov/advisory-committees/peripheral-and-central-nervous-system-drugs-advisory-committee/march-30-2022-meeting-peripheral-and-central-nervous-system-drugs-advisory-committee-meeting
Earlier Event: March 10
Cellular, Tissue, and Gene Therapies Advisory Committee
Later Event: April 6
Vaccines and Related Biological Products Advisory Committee